We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close


FDA Shames Anti-Generic Tactics, Putting Onus On Congress

Law360 (May 17, 2018, 10:20 PM EDT) -- The U.S. Food and Drug Administration on Thursday named and shamed drugmakers suspected of impeding lower-cost generics by withholding product samples, a splashy move that could jolt Congress into taking action....
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.